Joseph Stephen Pagano
#112,848
Most Influential Person Now
Joseph Stephen Pagano's AcademicInfluence.com Rankings
Joseph Stephen Paganobiology Degrees
Biology
#6347
World Rank
#9039
Historical Rank
Virology
#131
World Rank
#135
Historical Rank
Microbiology
#283
World Rank
#328
Historical Rank
Download Badge
Biology
Joseph Stephen Pagano's Degrees
- PhD Microbiology University of California, San Francisco
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Joseph Stephen Pagano Influential?
(Suggest an Edit or Addition)Joseph Stephen Pagano's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Epstein-Barr virus replication in oropharyngeal epithelial cells. (1984) (732)
- Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. (1968) (643)
- IRF7: activation, regulation, modification and function (2011) (388)
- Infectious agents and cancer: criteria for a causal relation. (2004) (333)
- Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. (1987) (282)
- Replication of Epstein–Barr virus in human epithelial cells infected in vitro (1983) (279)
- Induction of cyclooxygenase-2 by Epstein–Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells (2001) (271)
- IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency (1997) (263)
- The differentiated form of nasopharyngeal carcinoma contains epstein‐barr virus DNA (1987) (242)
- Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes (2014) (240)
- The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. (1998) (240)
- A SECOND SITE FOR EPSTEIN-BARR VIRUS SHEDDING: THE UTERINE CERVIX (1986) (233)
- Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. (1983) (223)
- Detection of Epstein-Barr viral genome in nonproductive cells. (1971) (222)
- DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. (1973) (220)
- Homology between Epstein-Barr Virus DNA and Viral DNA from Burkitt's Lymphoma and Nasopharyngeal Carcinoma determined by DNA-DNA Reassociation Kinetics (1973) (213)
- Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. (2007) (212)
- Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication (1980) (203)
- Infectious poliovirus RNA: a sensitive method of assay. (1965) (202)
- Cytotoxicity of sesquiterpene lactones. (1971) (200)
- Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. (2007) (184)
- Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. (1976) (181)
- Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1α (2004) (179)
- Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. (1972) (171)
- EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus (1991) (171)
- The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. (2004) (164)
- Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus (1984) (160)
- Human Cytomegalovirus I. Purification and Characterization of Viral DNA (1973) (160)
- Replication of EBV in epithelial cells during infectious mononucleosis (1977) (160)
- Viruses and Human Cancers: a Long Road of Discovery of Molecular Paradigms (2014) (154)
- The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters (1989) (151)
- Acyclovir inhibition of Epstein-Barr virus replication. (1980) (134)
- An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. (1988) (134)
- Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2 (1999) (134)
- Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial–mesenchymal transition in metastatic nasopharyngeal carcinoma (2011) (132)
- Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses (1977) (131)
- The Epstein-Barr Virus (EBV)-Encoded Protein Kinase, EBV-PK, but Not the Thymidine Kinase (EBV-TK), Is Required for Ganciclovir and Acyclovir Inhibition of Lytic Viral Production (2010) (130)
- EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. (2006) (128)
- Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma. (1973) (127)
- Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. (2000) (117)
- TRAF6 and the Three C-Terminal Lysine Sites on IRF7 Are Required for Its Ubiquitination-Mediated Activation by the Tumor Necrosis Factor Receptor Family Member Latent Membrane Protein 1 (2008) (116)
- Epstein-Barr virus transcription in nasopharyngeal carcinoma (1983) (111)
- Acyclovir and Epstein-Barr virus infection. (1983) (109)
- Epstein-Barr virus: the first human tumor virus and its role in cancer. (1999) (109)
- Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. (2004) (109)
- Interferon Regulatory Factor 7 Regulates Expression of Epstein-Barr Virus Latent Membrane Protein 1: a Regulatory Circuit (2003) (108)
- Structure and function of IRF-7. (2002) (108)
- Structural Polypeptides of Simian Virus 40 (1971) (105)
- Epstein-Barr virus infections: prospects for treatment. (2005) (104)
- Regulation of the Transcriptional Activity of the IRF7 Promoter by a Pathway Independent of Interferon Signaling* (2005) (103)
- Interferon Regulatory Factor 7 Is Negatively Regulated by the Epstein-Barr Virus Immediate-Early Gene, BZLF-1 (2005) (102)
- Epstein-Barr Virus Latent Membrane Protein 1 Induces Cancer Stem/Progenitor-Like Cells in Nasopharyngeal Epithelial Cell Lines (2011) (97)
- Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1 (1976) (95)
- Detection of human cytomegalovirus and analysis of strain variation. (1976) (94)
- Interferon Regulatory Factor 7 Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 (2000) (93)
- Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers. (2016) (90)
- Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. (2002) (89)
- Epstein-Barr Virus-Encoded Protein Kinase (BGLF4) Is Involved in Production of Infectious Virus (2007) (87)
- Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine (1987) (87)
- Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication (1987) (85)
- Conserved herpesvirus protein kinases. (2008) (85)
- Epstein‐Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes (2007) (83)
- Interferon Regulatory Factor 7 Is Activated by a Viral Oncoprotein through RIP-Dependent Ubiquitination (2007) (83)
- Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F (1996) (80)
- Factors Influencing the Enhancement of the Infectivity of Poliovirus Ribonucleic Acid by Diethylaminoethyl-Dextran (1967) (79)
- Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration (2009) (77)
- Inhibition of Epstein-Barr Virus Replication by a Benzimidazole l-Riboside: Novel Antiviral Mechanism of 5,6-Dichloro-2-(Isopropylamino)-1-β-l-Ribofuranosyl-1H-Benzimidazole (1999) (77)
- Reassociation Kinetics for Epstein-Barr Virus DNA: Nonhomology to Mammalian DNA and Homology of Viral DNA in Various Diseases (1973) (76)
- Intracellular Signaling Molecules Activated by Epstein-Barr Virus for Induction of Interferon Regulatory Factor 7 (2001) (75)
- The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent (1989) (75)
- Diseases and mechanisms of persistent DNA virus infection: latency and cellular transformation. (1975) (75)
- The Epstein-Barr Virus (EBV) Deubiquitinating Enzyme BPLF1 Reduces EBV Ribonucleotide Reductase Activity (2009) (74)
- New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. (2002) (73)
- Epstein-Barr Virus BPLF1 Deubiquitinates PCNA and Attenuates Polymerase η Recruitment to DNA Damage Sites (2012) (72)
- Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). (1965) (72)
- Phosphorylation of the Epstein-Barr Virus (EBV) DNA Polymerase Processivity Factor EA-D by the EBV-Encoded Protein Kinase and Effects of the l-Riboside Benzimidazole 1263W94 (2002) (72)
- Epstein‐Barr virus latent membrane protein 1 induces the matrix metalloproteinase‐1 promoter via an Ets binding site formed by a single nucleotide polymorphism: Enhanced susceptibility to nasopharyngeal carcinoma (2005) (71)
- Expression of EBNA-1 mRNA Is Regulated by Cell Cycle during Epstein-Barr Virus Type I Latency (1999) (70)
- The A20 Deubiquitinase Activity Negatively Regulates LMP1 Activation of IRF7 (2010) (68)
- Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells (1976) (68)
- Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis. (1975) (67)
- Interferon Regulatory Factor 7 Is Associated with Epstein-Barr Virus-Transformed Central Nervous System Lymphoma and Has Oncogenic Properties (2004) (65)
- Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor (1994) (65)
- Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta. (2010) (64)
- Transforming Growth Factor β/Smad3 Signaling Regulates IRF-7 Function and Transcriptional Activation of the Beta Interferon Promoter (2004) (64)
- Human Cytomegalovirus II. Lack of Relatedness to DNA of Herpes Simplex I and II, Epstein-Barr Virus, and Nonhuman Strains of Cytomegalovirus (1974) (64)
- Structure and Function of the Polypeptides in Simian Virus 40 I. Existence of Subviral Deoxynucleoprotein Complexes (1972) (63)
- Autologous and Homologous Implantation of Human Cells Transformed In Vitro by Simian Virus 40 (1964) (63)
- Tumor Viruses and Cell Signaling Pathways: Deubiquitination versus Ubiquitination (2004) (63)
- The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. (1998) (62)
- Targeting of host-cell ubiquitin pathways by viruses. (2005) (61)
- Interferon Regulatory Factor 7 Mediates Activation of Tap-2 by Epstein-Barr Virus Latent Membrane Protein 1 (2001) (61)
- Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA. (1979) (61)
- Interferon Regulatory Factor 2 Represses the Epstein-Barr Virus BamHI Q Latency Promoter in Type III Latency (1999) (61)
- Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter (2005) (60)
- Ubiquitin editing enzyme UCH L1 and microtubule dynamics: Implication in mitosis (2010) (59)
- Expression and Functional Studies of Ubiquitin C-Terminal Hydrolase L1 Regulated Genes (2009) (59)
- Epstein–Barr virus activates β-catenin in type III latently infected B lymphocyte lines: Association with deubiquitinating enzymes (2003) (58)
- The Epstein-Barr Virus Immediate-Early Gene Product, BRLF1, Interacts with the Retinoblastoma Protein during the Viral Lytic Cycle (1998) (58)
- Unconventional processing of the 3' termini of the Epstein-Barr virus DNA polymerase mRNA. (1993) (57)
- Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon (1991) (57)
- Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses. (1982) (56)
- Epstein-Barr Virus Latent Membrane Protein 1 Regulates the Function of Interferon Regulatory Factor 7 by Inducing Its Sumoylation (2012) (56)
- Epstein-Barr virus induces invasion and metastasis factors. (2003) (56)
- Expression and Localization of the Epstein-Barr Virus-Encoded Protein Kinase (2004) (56)
- Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) C-Terminal-Activating Region 3 Contributes to LMP1-Mediated Cellular Migration via Its Interaction with Ubc9 (2011) (56)
- Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. (1993) (55)
- Autologous human B and T lymphoblastoid cell lines (1974) (53)
- Field evaluation of live virus mumps vaccine. (1968) (53)
- Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. (1981) (53)
- Viruses and lymphomas. (2002) (53)
- Epstein-Barr virus: inhibition of replication by three new drugs. (1983) (53)
- Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate. Purification and characterization. (1980) (53)
- RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism (1994) (52)
- The Epstein-Barr Virus (EBV) SM Protein Enhances Pre-mRNA Processing of the EBV DNA Polymerase Transcript (1998) (51)
- The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line. (1974) (51)
- Multiple signal transducers and activators of transcription are induced by EBV LMP-1. (2004) (50)
- Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding. (1966) (50)
- Interferon Regulatory Factor 5 Represses Expression of the Epstein-Barr Virus Oncoprotein LMP1: Braking of the IRF7/LMP1 Regulatory Circuit (2005) (49)
- Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and β-Catenin/TCF Signaling (2009) (49)
- Matrix metalloproteinase 9 is induced by the Epstein–Barr virus BZLF1 transactivator (1999) (48)
- Treatment of life-threatening Epstein-Barr virus infection with acyclovir. (1982) (48)
- Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication (1991) (48)
- Sites of replication of chromosomal DNA in a eukaryotic cell. (1972) (47)
- Replication of Viral Deoxyribonucleic Acid and Breakdown of Cellular Deoxyribonucleic Acid in Epstein-Barr Virus Infection (1972) (46)
- Up-regulation of β-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells (2005) (45)
- Regulation of the Epstein-Barr virus DNA polymerase gene (1992) (43)
- MUC1 Induced by Epstein-Barr Virus Latent Membrane Protein 1 Causes Dissociation of the Cell-Matrix Interaction and Cellular Invasiveness via STAT Signaling (2006) (43)
- Two Cases of Fatal Inhalation Anthrax, One Associated with Sarcoidosis (1961) (41)
- Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus (1985) (40)
- Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy. (1994) (40)
- Knockout of Epstein-Barr Virus BPLF1 Retards B-Cell Transformation and Lymphoma Formation in Humanized Mice (2015) (40)
- Disparate effects of two herpesviruses immediate-early gene trans-activators on the HIV-1 LTR (1989) (40)
- Viruses as oncolytic agents: a new age for "therapeutic" viruses? (1994) (40)
- Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells. (1993) (39)
- Antiviral Drugs for EBV (2018) (38)
- Structural proteins of simian virus 40. I. Histone characteristics of low-molecular-weight polypeptides (1975) (38)
- Epstein-Barr virus-associated thymidine kinase (1978) (38)
- Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB). (1976) (37)
- Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus (1988) (37)
- Epstein-Barr virus DNA in Hodgkin's disease, American Burkitt's lymphoma, and other human tumors. (1974) (37)
- Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines (1981) (37)
- Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase (1985) (36)
- LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1 (2015) (36)
- Maribavir Inhibits Epstein-Barr Virus Transcription in Addition to Viral DNA Replication (2009) (35)
- Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis (1981) (33)
- Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RARα and RXRα (1995) (33)
- Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation. (2001) (33)
- Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture. (1979) (33)
- Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs. (2001) (33)
- Specific Complement-Fixing Tumor Antigen in SV40-Trans formed Human Cells.∗ (1965) (32)
- Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine (1989) (31)
- The uptake of SV40 DNA by nonpermissive cells in the presence of DEAE-dextran. (1971) (31)
- The Rad6/18 Ubiquitin Complex Interacts with the Epstein-Barr Virus Deubiquitinating Enzyme, BPLF1, and Contributes to Virus Infectivity (2014) (31)
- Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests. (1974) (31)
- Effects of Maribavir and Selected Indolocarbazoles on Epstein-Barr Virus Protein Kinase BGLF4 and on Viral Lytic Replication (2004) (31)
- Serologic testing for anthrax antibodies in workers in a goat hair processing mill. (1960) (30)
- Polypeptide synthesis and phosphorylation in Epstein-Barr virus-infected cells (1980) (29)
- Homology of Epstein-Barr virus DNA in nasopharyngeal carcinomas from Kenya, Taiwan, Singapore and Tunisia. (1975) (29)
- Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. (2005) (29)
- Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha. (1995) (29)
- Infections with cytomegalovirus in bone marrow transplantation: report of a workshop. (1975) (28)
- Dissociation of opsonized particle phagocytosis and respiratory burst activity in an Epstein-Barr virus-infected myeloid cell line (1980) (27)
- Simultaneous infection with multiple herpesviruses. (1979) (27)
- CHAPTER 4 – The Epstein-Barr Viral Genome and Its Interactions with Human Lymphoblastoid Cells and Chromosomes (1974) (27)
- Identification and functional characterization of Epstein-Barr virus DNA polymerase by in vitro transcription-translation of a cloned gene (1991) (27)
- Analysis of Simian Virus 40 DNA with the Restriction Enzyme of Haemophilus aegyptius, Endonuclease Z (1973) (26)
- Epstein-Barr virus and interactions with human retroviruses. (1988) (26)
- Maribavir Inhibits Epstein-Barr Virus Transcription through the EBV Protein Kinase (2013) (26)
- Variations in the responses of infants to living attenuated poliovirus vaccines. (1961) (26)
- Ribonucleotide reductase inhibitors enhance cidofovir‐induced apoptosis in EBV‐positive nasopharyngeal carcinoma xenografts (2005) (26)
- Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir. (1982) (26)
- Epstein‐Barr Viral Latency and Cell Immortalization as Targets for Antisense Oligomers a (1992) (25)
- C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes (2018) (25)
- Mitosis-Specific Hyperphosphorylation of Epstein-Barr Virus Nuclear Antigen 2 Suppresses Its Function (2004) (24)
- Plasmid origin of replication of herpesvirus papio: DNA sequence and enhancer function (1990) (24)
- Isolation from Animals of Human Strains of Staphylococci during an Epidemic in a Veterinary School (1960) (23)
- Synergistic Inhibition of Epstein-Barr Virus: Transformation of B Lymphocytes by α and γ Interferon and by 3′-Azido-3′-Deoxythymidine (1989) (23)
- A noncanonical poly(A) signal, UAUAAA, and flanking elements in Epstein-Barr virus DNA polymerase mRNA function in cleavage and polyadenylation assays. (1997) (23)
- Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retinoic acid and 9-(2-hydroxyethoxymethyl) guanine. (1981) (22)
- Epstein–Barr virus genome in infectious mononucleosis (1976) (22)
- Subpopulations of Human Lymphoblastoid Cell Lines (1976) (21)
- Small, Circular, Viral DNA: Preparation and Analysis of SV40 and ϕ X174 DNA (1971) (21)
- Is Epstein-Barr virus transmitted sexually? (2007) (21)
- Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody (1985) (21)
- Epstein-Barr virus DNA synthesized in superinfected Raji cells. (1977) (21)
- Explantation and subculture of epithelial cells from human uterine ectocervix. (1980) (20)
- Upregulation of special AT-rich-binding protein 1 by Epstein-Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer. (2013) (20)
- Induction of DNA polymerase activity after superinfection of Raji cells with Epstein-Barr virus. (1980) (19)
- The Epstein-Barr Virus and malignancy: molecular evidence. (1975) (19)
- PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells (2011) (17)
- Cultured "hairy cells" infected with Epstein-Barr virus: evidence for B-lymphocyte origin. (1979) (17)
- Role of the ubiquitin system and tumor viruses in AIDS-related cancer (2007) (17)
- The specificity and interaction with poliovirus of an inhibitory bovine serum. (1965) (17)
- Effects of 12-O-tetradecanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication. (1982) (17)
- Detection of Epstein-Barr virus DNA in human tumors. (1975) (17)
- Murine cytomegalovirus infection of epithelial cells in mouse tracheal ring organ culture. (1977) (16)
- Interferon production and activation of non‐specific effector cells by stimulation with lymphoblastoid cell lines in vitro (1981) (16)
- Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells (2019) (16)
- Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter (1983) (16)
- KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation. (2014) (15)
- The response of premature infants to infection with attenuated poliovirus. (1962) (15)
- Inhibition of Human Immunodeficiency Virus Type 1 Replication by Guanosine Analogues and Lack of Synergistic Antiviral Effect of Acyclovir with 3′-azido-3′-deoxythymidine (1991) (15)
- Routine immunization with orally administered attenuated poliovirus. A study of 850 children in an American city. (1960) (15)
- The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1 (2017) (15)
- Structure and Function of the Polypeptides in Simian Virus 40 II. Transcription of Subviral Deoxynucleoprotein Complexes In Vitro (1972) (15)
- Epstein-Barr virus: culprit or consort? (1992) (14)
- Phosphorylation of acyclovir in vitro in activated Burkitt somatic cell hybrids (1983) (14)
- Detection of viral genes and their products in chronic neurological diseases (1984) (13)
- THE RESPONSE AND THE LACK OF SPREAD IN SWEDISH SCHOOL CHILDREN GIVEN AN ATTENUATED POLIOVIRUS VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN. (1964) (13)
- Epstein-Barr Virus Polypeptides: Identification of Early Proteins and Their Synthesis and Glycosylation (1981) (13)
- Induction of Epstein-Barr Virus-associated DNA (1980) (13)
- cdc2/Cyclin B1-Dependent Phosphorylation of EBNA2 at Ser243 Regulates Its Function in Mitosis (2006) (13)
- Cancer Progression Goes Viral: The Role of Oncoviruses in Aggressiveness of Malignancies. (2018) (13)
- Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid (1978) (12)
- Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells (2019) (12)
- Iodination of herpesvirus nucleic acids (1975) (12)
- Epstein-Barr virus-induced deoxynuclease and the reutilization of host-cell DNA degradation products in viral DNA replication. (1981) (12)
- Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine. (1983) (12)
- Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines. (1985) (12)
- Variation of response in early life to vaccination with living attenuated polivirus and lack of immunologic tolerance. (1960) (11)
- EQUINE AND BOVINE SERUMS AND DEXTRAN SULFATE AS GENETIC MARKERS OF POLIO VIRUS * (1965) (11)
- Synthesis of Epstein-Barr virus DNA in vitro: effects of phosphonoacetic acid, N-ethylmaleimide, and ATP (1977) (11)
- The Epstein‐Barr Virus and Nasopharyngeal Carcinoma (1994) (11)
- Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma. (1995) (11)
- Human ectocervical and endocervical epithelial cells in culture: a comparative ultrastructural study. (1980) (10)
- Long-term mouse cytomegalovirus infection of tracheal organ culture: relation to host cell replication. (1982) (10)
- Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function (1986) (10)
- THE RESPONSE OF PREMATURE INFANTS TO INFECTION WITH TYPE 3 ATTENUATED POLIOVIRUS. (1964) (10)
- Analysis of the Epstein-Barr virus origin of plasmid replication (oriP) reveals an area of nucleosome sparing that spans the 3' dyad (1989) (10)
- Sequential detection of different antigens induced by Epstein-Barr virus and herpes simplex virus in the same Western blot by using dual antibody probes (1986) (10)
- A microtiter plate technique for the agglutination typing of Diplococcus pneumoniae. (1970) (9)
- Rapid microtiter method for cytotoxicity screening. (1972) (9)
- Detection of autonomous replicating sequences (ars) in the genome of Epstein-Barr virus. (1983) (9)
- Long-term persistence of AZT-resistance mutations in the plasma HIV-1 of patients removed from AZT therapy. (1994) (9)
- Biologic activity of isolated viral nucleic acids. (1970) (9)
- Cellular transformation by the herpesviruses and antiviral drugs. (1985) (9)
- The pathogenesis and prevention of human cytomegalovirus infection (1984) (8)
- Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3'-azido-3'-deoxythymidine. (1989) (8)
- Synthesis of chromosomal proteins and Epstein-Barr virus DNA in activated Burkitt somatic cell hybrids. (1980) (8)
- Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1 (1993) (8)
- Hybridization of Viral Nucleic Acids: Newer Methods on Solid Media and in Solution (1984) (8)
- Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma (1988) (8)
- T antigen of BK papovavirus in infected and transformed cells (1978) (8)
- Expression of interferon regulatory factor 7 correlates with the expression of Epstein–Barr Virus latent membrane protein 1 and cervical lymph node metastasis in nasopharyngeal cancer (2017) (7)
- Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication. (1992) (7)
- Differential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line (1987) (7)
- THE EPSTEIN-BARR VIRUS PLASMID (1979) (6)
- Pathogenesis of infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma: a unified scheme. (1978) (6)
- Regulation of EBV Promoters (1987) (6)
- Replication of Epstein-Barr virus DNA in epithelial cells in vivo. (1978) (6)
- Prevention of infections with cytomegalovirus. (1976) (6)
- Replication of cytomegalovirus DNA in human lymphoblastoid cells. (1975) (6)
- Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome. (1989) (6)
- Epithelial Cell Interactions of the Epstein-Barr Virus (1984) (6)
- Molecular Probes and Genome Homology (1979) (6)
- Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain): preliminary report. (1967) (5)
- Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients (2018) (5)
- Epstein-Barr Virus (2009) (5)
- Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1. (2019) (5)
- Barr virus BRLF 1 inhibits transcription of IRF 3 and IRF 7 and suppresses induction of interferon-β (2010) (5)
- Molecular pathobiology of EBV infection. (2010) (5)
- Epstein-Barr Virus Latent Membrane Protein 1 ( LMP 1 ) C-Terminal-Activating Region 3 Contributes to LMP 1-Mediated Cellular Migration via Its Interaction with Ubc 9 (2011) (5)
- VACCINATION AGAINST CYTOMEGALOVIRUS (1974) (5)
- LMP 1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP 1 (2015) (4)
- Epstein-Barr Virus (Infectious Disease and Therapy) (2006) (4)
- The A 20 Deubiquitinase Activity Negatively Regulates LMP 1 Activation of IRF 7 (2010) (4)
- STUDIES OF THE VACCINE VIRUS ISOLATED DURING A TRIAL WITH AN ATTENUATED POLIOVIRUS VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN, INCLUDING USE OF A STRAIN SPECIFIC BOVINE SERUM INHIBITOR. (1964) (4)
- Enhancement of viral infectivity with DEAE-dextran: application to development of vaccines. (1967) (4)
- Activity of benzimidazole riboside 1263W94 (5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole) against Epstein-Barr virus (1997) (4)
- Burkitt's and other non-Hodgkin's lymphomas in adults exposed to a visitor from Africa. (1985) (4)
- Biotin-labeled DNA probes for detection of Epstein-Barr virus by in-situ cytohybridization. (1985) (3)
- Effect of 5-iodo-2'-deoxyuridine on physical properties and nonhistone chromosomal proteins of chromatin from Burkitt somatic cell hybrids. (1980) (3)
- Molecular epidemiology of epstein barr virus infection a perspective (1986) (3)
- Epstein-Barr Virus and Human Disease · 1990 (1991) (3)
- Detection of Epstein-Barr virus with molecular hybridization techniques. (1991) (3)
- Epstein-Barr Virus and Human Disease • 1988 (2011) (2)
- Molecular Mechanisms of Transformation by Epstein-Barr Virus (1995) (2)
- A New Lymphoid-Specific Epstein-Barr Virus Enhancer is Transactivated by EBNA-2 (1991) (2)
- A case of intrauterine fetal death after a negative oxytocin challenge test. (1978) (2)
- Cytotoxicity of Sesquiterpene Lactones 1 (2006) (2)
- Epstein-Barr virus and its antigens. (1989) (2)
- The pathogenesis and prevention of human cytomegalovirus infection. Report of a conference. (1984) (1)
- A second site for Epstein‐Barr virus shedding: The uterine cervix (1987) (1)
- Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR. (1989) (1)
- Challenges in the Treatment of EBV-Associated Diseases: New Approaches (1989) (1)
- Epstein Barr virus transformation of human lymphocytes in the presence of acyclovir [9-(2-hydroxyethoxymethyl)guanine] (1982) (1)
- From the National Institute of Allergy and Infectious Diseases Factors Associated with the Pathogenesis of AIDS (1987) (1)
- Induction and Regulation of Expression of the Epsteinbarr Virus DNA Polymerase Gene (1991) (1)
- Cultivation of epithelial cells from human uterine ectocervix (1985) (1)
- A Perspective on Treatment of EBV Infection States (1985) (1)
- Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial. (1971) (1)
- HIV Co-infection Augments EBV-Induced Tumorigenesis in vivo (2022) (1)
- Identification of LSc2ab Strain of Type 1 Poliovirus by Inhibition With Horse Serum and Dextran Sulfate.∗ (1966) (1)
- Uterotubal implantation and successful pregnancy following laparoscopic tubal cauterization. (1977) (1)
- Ectopic pregnancies after laparoscopic tubal sterilization. (1978) (1)
- Cancer Stem/Progenitor-like Cells in Nasopharyngeal 2 (2011) (1)
- Is Epstein-Barr virus transmitted sexually? [editorial] (2007) (1)
- Pathogenesis and treatment of Epstein-Barr virus infection. (1987) (1)
- Attenuated Poliovirus Vaccines grown in Human Diploid Cell Strains for the Immunization of Infants. (1966) (1)
- Induction of synthesis of Epstein-Barr virus DNA and virus-specific polypeptides by tumor promoter is enhanced by non-proliferative state of cells (1982) (0)
- Epstein-Barr Virus in a Malignant Lymphoproliferative Disorder of B-Cells Occurring after Thymic Epithelial Transplantation for Combined Immunodeficiency1 (2006) (0)
- UCH-L1 in DLBCL: marker or target? (2016) (0)
- Unknown hazards of infection. (1968) (0)
- An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat (herpesvirus/acquired immunodeflciency syndrome/gene promoters/chloramphenicol acetyltransferase assay/Si nuclease) (2016) (0)
- The Epstein-Barr Virus (EBV) Deubiquitinating Enzyme BPLF1 Reduces EBV Ribonucleotide Reductase Activity (cid:1) (2009) (0)
- Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells (2019) (0)
- Epstein-Barr virus and associated diseases : abstracts of papers presented at the Cold Spring Harbor Meeting on Cancer cells, September 7-September 11, 1994 (1994) (0)
- Use of topical acyclovir. (1983) (0)
- EBV LMP1 Induces the Sumoylation of Interferon Regulatory Factor 7 (2008) (0)
- Letter: Vaccination against cytomegalovirus? (1974) (0)
- Considerations of viral etiology causes and effects (1984) (0)
- SEARCH OF NEW DRUGS ACTIVE AGAINST EPSTEIN-BARR VIRUS (0)
- Human Tumor Viruses: A Historical Perspective (2015) (0)
- H-103 Speaking in honor of Peter Vogt: The Epstein-Barr Virus, a 50 year Odyssey (2017) (0)
- Epstein-Barr Virus in a Malignant Lymphoproliferative Disorder of B-Cells Occurring after Thymic Epithelial Transplantation for Combined Immunodeficiency 1 (2006) (0)
- Detection of Proteins Binding to the EBV EBNA-2 Promoter (1989) (0)
- II. LackofRelatedness toDNA ofHerpes Simplex IandII, Epstein-Barr Virus, andNonhumanStrains ofCytomegalovirus (1974) (0)
- Epstein-Barr Virus DNA in Hodgkin's Disease, American Burkitt's Lymphoma, and Other Human Tumors1 (2006) (0)
- Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) C-Terminal-Activating Region 3 Contributes to LMP1-Mediated Cellular Migration via Its Interaction with Ubc9 (cid:1) (2011) (0)
- PLOS Pathogens 2017 Reviewer and Editorial Board Thank You (2018) (0)
- Acyclovir comes of age. (1982) (0)
- Ubiquitination Pathways : Deubiquitination versus Tumor Viruses and Cell Signaling (2004) (0)
- Methods in Virology: Edited by Karl Maramorosch and Hilary Koprowski. Academic Press, New York and London, 1967, Vol. II, 682 pp., $28.00 (1968) (0)
- DNA viruses and cancer (1985) (0)
- Interferon Regulatory Factor 7 Is Activated by a Viral Oncoprotein through RIP-Dependent Ubiquitination (cid:1) (2007) (0)
- TheEpstein-Barr VirusImmediate-Early GeneProduct, BMLF1, Actsintransbya Posttranscriptional Mechanism WhichIs Reporter GeneDependent (1989) (0)
- A study of risk factors for acquisition of epstein-barr virus and its subtypes. Commentary (2007) (0)
- [Immunization of 850 children of Philadelphia with attenuated poliomyelitis virus. Preliminary report]. (1961) (0)
- 182 Growth of Epstein-Barr virus-immortalized cell lines is inhibited by specific antisense oligodeoxyribonucleotides (1993) (0)
- Epstein-Barr Virus Latent Membrane Protein 1 Induces and Causes Release of Fibroblast Growth Factor-21 (2002) (0)
- Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus ( acquired immunodeficiency syndrome / herpesvirus / chloramphenicol (0)
- Insurance coverage of screening mammography and Pap smears. The directors of North Carolina's University-based cancer centers speak out. (1991) (0)
- Resumption ofVirusProduction after HumanImmunodeficiency VirusInfection ofT Lymphocytes inthePresence of Azidothymidine (1987) (0)
- P3HR-1-Like Nontransforming Virus in Saliva and Peripheral Blood Lymphocytes in Chronic Active EBV Infection (1987) (0)
- Effect of 5-iodo-2'-deoxyuridine on properties of chromatin and synthesis on nonhistone chromosomal protein in Burkitt somatic cell hybrids (1979) (0)
- Functional Characterization of Epstein-Barr Virus DNA Polymerase by in VitroTranscription-Translation of Cloned Genes (1991) (0)
- DNA tumor viruses. (1984) (0)
- Type 3 poliovirus vaccines. (1969) (0)
- Analysis oftheEpstein-Barr VirusOrigin ofPlasmid Replication (oriP) Reveals an AreaofNucleosome Sparing That Spansthe3'Dyad (1989) (0)
- Perspective on cytomegalovirus. (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joseph Stephen Pagano?
Joseph Stephen Pagano is affiliated with the following schools:
